Trials / Conditions / CDKL5 Deficiency Disorder
CDKL5 Deficiency Disorder
6 registered clinical trials studyying CDKL5 Deficiency Disorder — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less NCT05249556 | Immedica Pharma AB | Phase 3 |
| Completed | The Association Between Fever and CDKL5 Deficiency Disorder: a Nationwide Survey NCT06663163 | Xuanwu Hospital, Beijing | — |
| Completed | Efficacy and Safety Evaluation of Hyperthermic Baths in the Treatment of Seizures in CDKL5 Deficiency Disorder NCT06447675 | Xuanwu Hospital, Beijing | N/A |
| Active Not Recruiting | A Study to Investigate the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder NCT05064878 | Zogenix, Inc. | Phase 3 |
| Recruiting | International CDKL5 Clinical Research Network NCT05558371 | University of Colorado, Denver | — |
| Completed | Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder NCT03572933 | Marinus Pharmaceuticals | Phase 3 |